|
CTPS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.78310707813034E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.22449885973242E-11 |
| Normal-vs-Stage2 |
1.045100E-04 |
| Normal-vs-Stage3 |
2.89629999983276E-08 |
| Normal-vs-Stage4 |
3.79070000000592E-05 |
| Stage1-vs-Stage2 |
8.545400E-01 |
| Stage1-vs-Stage3 |
7.394000E-01 |
| Stage1-vs-Stage4 |
8.567400E-01 |
| Stage2-vs-Stage3 |
9.735200E-01 |
| Stage2-vs-Stage4 |
7.597000E-01 |
| Stage3-vs-Stage4 |
6.739000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20576898360514E-12 |
| Normal-vs-AfricanAmerican |
9.165600E-04 |
| Normal-vs-Asian |
1.55448999999974E-05 |
| Caucasian-vs-AfricanAmerican |
9.372100E-02 |
| Caucasian-vs-Asian |
4.487200E-01 |
| AfricanAmerican-vs-Asian |
4.192000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32600000038552E-07 |
| Normal-vs-Female |
2.99182900675987E-12 |
| Male-vs-Female |
3.821800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.90799981054136E-10 |
| Normal-vs-Age(41-60Yrs) |
7.51119999531369E-08 |
| Normal-vs-Age(61-80Yrs) |
1.14710000387319E-08 |
| Normal-vs-Age(81-100Yrs) |
2.872000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.168100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.431000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.525200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.181700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.055000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.484400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.443000E-01 |
| Classical-VS-Follicular |
5.731600E-01 |
| Classical-VS-Other |
1.131820E-01 |
| Classical-VS-Normal |
3.58935103861313E-12 |
| Tall-VS-Follicular |
5.120800E-01 |
| Tall-VS-Other |
1.272770E-01 |
| Tall-VS-Normal |
3.352600E-04 |
| Follicular-VS-Other |
3.135400E-01 |
| Follicular-VS-Normal |
9.6753000000005E-05 |
| Other-VS-Normal |
6.727200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61369995144156E-09 |
| Normal-vs-N1 |
1.360240E-03 |
| N0-vs-N1 |
8.843200E-01 |
|
|
